Results 181 to 190 of about 575,974 (287)

Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED‐AHF): A prospective, randomized, mechanistic study

open access: yesEuropean Journal of Heart Failure, EarlyView.
The impact of sodium chloride (NaCl) supplementation on proximal and distal tubular reabsorption in acute heart failure (AHF). Abstract Aims We questioned the long‐standing paradigm that sodium/chloride restriction is essential for effective decongestion in acute heart failure (AHF). This study compared the decongestive effects of two isotonic infusion
Jan Biegus   +7 more
wiley   +1 more source

The journey continues in Clinical Diabetes and Endocrinology

open access: yesClinical Diabetes and Endocrinology, 2018
Ariel Barkan   +2 more
doaj   +1 more source

Editorial: Debates in clinical management in pediatric endocrinology, volume II

open access: yesFrontiers in Endocrinology, 2023
Gianpaolo De Filippo   +2 more
doaj   +1 more source

Acute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides

open access: yesEuropean Journal of Heart Failure, EarlyView.
Cancer patients presenting to the emergency department ED with dyspnoea. Among 2153 patients presenting to the ED with dyspnea, 473 (22.0%) had an active or past cancer. Acute heart failure (AHF) was the most common final diagnosis in both groups. Pneumonia and cancer‐related dyspnoea were more common in cancer patients.
Paolo Bima   +20 more
wiley   +1 more source

Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon‐like peptide‐1 receptor agonists. European Journal of Heart Failure expert consensus document

open access: yesEuropean Journal of Heart Failure, EarlyView.
There is growing clinical interest in strategies for improving clinical outcomes in patients with heart failure (HF) and obesity. The development of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and of the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 RA has expanded therapeutic options for this population. This expert consensus
Luca Monzo   +13 more
wiley   +1 more source

Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?

open access: yesFuture Science OA, 2023
Sarvesh Sabarathinam   +2 more
doaj   +1 more source

BASIC AND CLINICAL ENDOCRINOLOGY

open access: green, 1984
Francis S. Greenspan
openalex   +2 more sources

Home - About - Disclaimer - Privacy